Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Tips and best practices for empowering professionals to become change agents in their institutions, including clinical trials ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Q1 2025. Management View. CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS.

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

The words that followed meant nothing to me but turned out to be the first lines of the Iliad, which translate into English ...

Welcome to Edition 7.30 of the Rocket Report! The US government relies on SpaceX for a lot of missions. These include ...

From Ad Age’s count, only four celebrities starring in this year’s Big Game ads are openly part of the LGBTQ+ community: ...

Please be advised that today's conference is being recorded. I would now like to hand the conference over to Sally Schwartz, Vice President of Investor Relations. Hello everyone and welcome to our ...

Stocks Analysis by MarketBeat.com (Jeffrey Neal Johnson) covering: Rocket Lab USA, Inc.. Read MarketBeat.com (Jeffrey Neal Johnson)'s latest article on Investing.com ...